117 related articles for article (PubMed ID: 1357216)
41. Prognostic value of DNA ploidy and proliferating cell nuclear antigen in gastric cancer.
Hirose K; Iida A; Yamaguchi A; Onchi H; Awata H; Katayama K; Nakagawara G
Oncology; 1998; 55(4):300-6. PubMed ID: 9663419
[TBL] [Abstract][Full Text] [Related]
42. DNA ploidy and proliferating cell nuclear antigen in colonic adenomas and adenocarcinomas.
Tomita T
Dig Dis Sci; 1995 May; 40(5):996-1004. PubMed ID: 7729290
[TBL] [Abstract][Full Text] [Related]
43. DNA flow cytometry, p53 levels and proliferative cell nuclear antigen in human colon dysplastic, precancerous and cancerous tissues.
Barletta A; Marzullo F; Pellecchia A; Montemurro S; Labriola A; Lomonaco R; Grammatica L; Paradiso A
Anticancer Res; 1998; 18(3A):1677-82. PubMed ID: 9673389
[TBL] [Abstract][Full Text] [Related]
44. Morphometric determination of AgNORs in breast carcinoma. Correlation with flow cytometry and proliferating cell nuclear antigen.
Bellotti M; Elsner B; Kahn A; Bezodnick L; Pisilli L; Greco P
Anal Quant Cytol Histol; 1997 Apr; 19(2):139-44. PubMed ID: 9113306
[TBL] [Abstract][Full Text] [Related]
45. DNA ploidy and PCNA index in pancreatic lesions producing hyperinsulinemic hypoglycemia.
Losada J; Sarria R; Fernandez Val JF; Lopez Ariztegui MA
J Surg Oncol; 1995 May; 59(1):14-7. PubMed ID: 7745970
[TBL] [Abstract][Full Text] [Related]
46. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
[TBL] [Abstract][Full Text] [Related]
47. Nuclear DNA content, proliferating-cell nuclear antigen (PCNA) and p53 immunostaining in predicting progression of laryngeal cancer in situ lesions.
Munck-Wikland E; Edström S; Jungmark E; Kuylenstierna R; Lindholm J; Auer G
Int J Cancer; 1994 Jan; 56(1):95-9. PubMed ID: 7903288
[TBL] [Abstract][Full Text] [Related]
48. Flow cytometry analysis of pituitary adenomas.
Fornas O; Mato ME; Viader M; Oliver B; Tresserres P; Bartumeus F; Tugues D; Pétriz J; Matías-Guiu X; Webb SM
Horm Res; 1996; 46(6):257-62. PubMed ID: 8982735
[TBL] [Abstract][Full Text] [Related]
49. Prognostic significance of cellular proliferation in renal cell carcinoma: a comparison of synthesis-phase fraction and proliferating cell nuclear antigen index.
Grignon DJ; Abdel-Malak M; Mertens W; Koster J; Keeney M; Sakr W; Shepherd RR
Mod Pathol; 1995 Jan; 8(1):18-24. PubMed ID: 7731937
[TBL] [Abstract][Full Text] [Related]
50. [Analysis of nuclear DNA heterogeneity of the hepatocellular carcinoma (HCC)].
Horiuchi H; Yamashita Y; Kamachi M; Sendo S; Kobayashi K; Yanase Y; Nakamura Y; Kakegawa T; Nakashima T
Gan To Kagaku Ryoho; 1994 May; 21 Suppl 1():11-6. PubMed ID: 7515614
[TBL] [Abstract][Full Text] [Related]
51. Pleomorphic adenoma and adenoid-cystic carcinoma of salivary glands: immunohistochemical assessment of proliferative activity in comparison with flow-cytometric study.
Daniele E; Tralongo V; Morello V; Nagar C; Russo A; Bazan V; Dardanoni G; Ciotta S; Nuara R; Tomasino RM
Cell Prolif; 1996 Mar; 29(3):153-62. PubMed ID: 8652744
[TBL] [Abstract][Full Text] [Related]
52. [Correlation of intratumor DNA ploidy distribution pattern and Ki-67 index in large bowel carcinomas].
Sasaki O; Hamatake M; Yasuda M; Soejima K
Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():181-5. PubMed ID: 7611787
[TBL] [Abstract][Full Text] [Related]
53. Proliferating cell nuclear antigen expression in renal cell carcinoma. Prognostic implications.
Larsson P; Roos G; Stenling R; Ljungberg B
Scand J Urol Nephrol; 1996 Dec; 30(6):445-50. PubMed ID: 9008023
[TBL] [Abstract][Full Text] [Related]
54. DNA ploidy and proliferating cell nuclear antigen image analysis of peritoneal and pleural effusions. A possible diagnostic role.
el-Habashi AH; Freeman SM; el-Morsi B; el-Didi M; Martin A; Marrogi AJ
Acta Cytol; 1997; 41(3):636-48. PubMed ID: 9167676
[TBL] [Abstract][Full Text] [Related]
55. Genesis and evolution of high-ploidy tumour cells evaluated by means of the proliferation markers p34(cdc2), cyclin B1, PCNA and 3[H]-thymidine.
Baroja A; de la Hoz C; Alvarez A; Ispizua A; Bilbao J; de Gandarias JM
Cell Prolif; 1996 Feb; 29(2):89-100. PubMed ID: 8630339
[TBL] [Abstract][Full Text] [Related]
56. [The evaluation of proliferating activity in gastric carcinoma stained by proliferating cell nuclear antigen (PCNA): preliminary report].
Nakano H; Namatame K; Suzuki T; Nakayoshi A; Kumada K
Nihon Geka Gakkai Zasshi; 1992 Feb; 93(2):216. PubMed ID: 1348104
[No Abstract] [Full Text] [Related]
57. The significance of proliferating cell nuclear antigen (PCNA) expression in cancer of the ampulla of vater in terms of prognosis.
Isozaki H; Okajima K; Ichinona T; Tanimura M; Morita S; Takada Y; Ishibashi T; Hara H
Surg Today; 1994; 24(6):494-9. PubMed ID: 7919730
[TBL] [Abstract][Full Text] [Related]
58. The prognostic value of immunohistochemical staining for proliferating cell nuclear antigen in synovial sarcoma.
Oda Y; Hashimoto H; Takeshita S; Tsuneyoshi M
Cancer; 1993 Jul; 72(2):478-85. PubMed ID: 8100481
[TBL] [Abstract][Full Text] [Related]
59. Polymorphous low-grade adenocarcinoma: flow cytometric, p53, and PCNA analysis.
Kelsch RD; Bhuiya T; Fuchs A; Gentile P; Kahn MA; Fantasia JE
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1997 Oct; 84(4):391-9. PubMed ID: 9347503
[TBL] [Abstract][Full Text] [Related]
60. Prognostic significance of proliferating cell nuclear antigen expression in hepatocellular carcinoma.
Ng IO; Lai EC; Fan ST; Ng M; Chan AS; So MK
Cancer; 1994 May; 73(9):2268-74. PubMed ID: 7513246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
